Prevention of Seasonal Affective Disorder

Completed · Phase 3

Conditions studied: Seasonal Affective Disorder (SAD)

In brief

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Key facts

Study ID

NCT00046449

Run by

GlaxoSmithKline

Starts

2002-09-01

Expected to finish

2003-06-01

Last updated by the study team

2015-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study Site — New Haven, Connecticut, United States
• Study Site — Newark, Delaware, United States
• Study Site — Wilmington, Delaware, United States
• Study Site — Washington D.C., District of Columbia, United States
• Study Site — Washington D.C., District of Columbia, United States
• Study Site — Boise, Idaho, United States
• Study SIte — Chicago, Illinois, United States
• Study Site — Chicago, Illinois, United States
• Study Site — Hoffman Estates, Illinois, United States
• Study Site — Libertyville, Illinois, United States
• Study SIte — Northfield, Illinois, United States
• Study Site — Schaumburg, Illinois, United States
• Study SIte — Greenwood, Indiana, United States
• Study Site — Indianapolis, Indiana, United States
• Study Site — Florence, Kentucky, United States
• Study Site — Wellesley Hills, Massachusetts, United States
• Study Site — Okemos, Michigan, United States
• Study Site — Royal Oak, Michigan, United States
• Study Site — Minneapolis, Minnesota, United States
• Study Site — Moorestown, New Jersey, United States
• Study Site — Piscataway, New Jersey, United States
• Study Site — Amityville, New York, United States
• Study Site — Lawrence, New York, United States
• Study Site — New York, New York, United States
• Study Site — Homer, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.